Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 138 views
- Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage 79 views
- InnerScope Hearing Technologies (OTC: INND) Launches Its iHEAR Brand of OTC Hearing Aids on CVS.com 76 views
- Google Gives Spotify its Own In-App Payment Option as Part of a New Pilot 74 views
- China Unveils Maglev Train With a Top Speed of 600 kph 71 views